- Pfizer (Groton, CT)
- …(GDL)and members of the development team to establish, lead, coordinate, and execute the early oncology clinical development plan(s). You will lead the ... disciples to ensure the full scope and remit of Oncology Early Stage Development (OESD)...understanding of Oncology Drug Development especially in Early Development + Strong knowledge of clinical … more
- Sumitomo Pharma (Hartford, CT)
- …marketed products in the US, Canada, and Europe, and a diverse pipeline of early - to late- stage assets, we aim to accelerate discovery, research, and development ... therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery,… more
- Sumitomo Pharma (Hartford, CT)
- …marketed products in the US, Canada, and Europe, and a diverse pipeline of early - to late- stage assets, we aim to accelerate discovery, research, and development ... therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery,… more
- Sumitomo Pharma (Hartford, CT)
- … landscape + Experience in conducting global clinical trials in both early - and late- stage clinical development, especially protocol development and ... Pharma Switzerland GmbH) focused on addressing patient needs in oncology , urology, women's health, rare diseases, psychiatry & neurology,...concept to clinical study protocol for both early - and late- stage programs + Leads or… more
- Sumitomo Pharma (Hartford, CT)
- …marketed products in the US, Canada, and Europe, and a diverse pipeline of early - to late- stage assets, we aim to accelerate discovery, research, and development ... colleagues across the SMPA organization including, but not limited to, Clinical Development, Translational Medicine/ Early Development, Regulatory Affairs, Data… more
- Sumitomo Pharma (Hartford, CT)
- …marketed products in the US, Canada, and Europe, and a diverse pipeline of early - to late- stage assets, we aim to accelerate discovery, research, and development ... therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery,… more
- Sumitomo Pharma (Hartford, CT)
- …marketed products in the US, Canada, and Europe, and a diverse pipeline of early - to late- stage assets, we aim to accelerate discovery, research, and development ... therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery,… more
- Sumitomo Pharma (Hartford, CT)
- …therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery, ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim… more
- Sumitomo Pharma (Hartford, CT)
- …marketed products in the US, Canada, and Europe, and a diverse pipeline of early - to late- stage assets, we aim to accelerate discovery, research, and development ... therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery,… more
- Sumitomo Pharma (Hartford, CT)
- …marketed products in the US, Canada, and Europe, and a diverse pipeline of early - to late- stage assets, we aim to accelerate discovery, research, and development ... therapies and CNS. With several marketed products and a diverse pipeline of early - to late- stage investigational assets, we aim to accelerate discovery,… more